Diagnostic Performance of the Vesical Imaging-Reporting and Data System for Predicting Muscle Invasion in Bladder Cancer
Background and aimAccurate assessment of muscle invasion in bladder cancer is essential for appropriate treatment planning.The Vesical Imaging-Reporting and Data System (VI-RADS) was developed to standardize magnetic resonance imaging (MRI) interpretation and improve the prediction of muscle-invasive bladder cancer.This study aimed to retrospectively evaluate the diagnostic performance of 1.5-T multiparametric MRI using a predefined VI-RADS threshold of ≥4 for predicting muscularis propria invasion (≥T2) in patients with primary or recurrent urothelial bladder carcinoma who underwent MRI within one month before transurethral resection of bladder tumor (TURBT), using histopathological findings as the reference standard. MethodsThis retrospective, single-center observational study was conducted at the Department of Urology, Mohammed V Military Hospital, between January 2020 and December 2025.A total of 135 patients with primary or recurrent bladder tumors who underwent bladder MRI before transurethral resection of bladder tumor (TURBT) were included.MRI examinations were interpreted by senior radiologists, and VI-RADS scores were compared with histopathological findings.Diagnostic performance was evaluated by calculating sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy. ResultsThe study included 135 patients with a mean age of 60±7.46 years, including 117 men (86.7%).A history of smoking was reported in 124 patients (91.9%).Among 81 patients with VI-RADS scores ≥4, muscle invasion was confirmed histopathologically in 75 (92.6%)patients.Among 54 patients with VI-RADS scores ≤3, 51 (94.4%) had non-muscle-invasive disease.Using a VI-RADS cutoff of ≥4, sensitivity was 96.2%, specificity was 89.5%, positive predictive value was 92.6%, negative predictive value was 94.4%, and overall diagnostic accuracy was 93.3%. ConclusionsUsing a predefined threshold of ≥4, VI-RADS demonstrated high diagnostic accuracy for predicting muscularis propria invasion in this selected retrospective cohort.These findings suggest that VI-RADS may serve as a complementary non-invasive tool for preoperative assessment, without replacing histopathological confirmation.Further prospective studies are needed to validate its clinical utility.
Authors
- Mohammed Mrabti
- Larbi Hamedoun (ORCID: https://orcid.org/0000-0002-1886-3520)
- Amine Cherraqi (ORCID: https://orcid.org/0000-0003-1838-4631)
- Tarik CHMITAH
- Ahmed Ameur
- Alaa Sobhi (ORCID: https://orcid.org/0000-0001-6963-0885)
- Abdessamad El Bahri
- Mohamed Tetou
- Mohammed Alami
Publication Details
- Journal
- Cureus
- Published
- 2026-11-14
- DOI
- https://doi.org/10.7759/cureus.119650
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00